Position in RVMD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,020,369,609
+$593,754,185 QoQ
Shares Held
5,450,825
+24.2% QoQ
Ownership
2.54%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#11
of 687 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in RVMD Over Time
Shares Held
Position Value (USD)
Derivatives in RVMD
reported options exposure · as of Jun 30, 2026CallValue
$1,310,960
CallShares
7,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. RVMD ranks #1 (11.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
This page
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in RVMD
Export CSV
34 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 RVMDW | — | 2,461 | Shares | Defined | 2026-08-13 | |
| 2026-06-30 | $1,020,369,609 | 5,448,364 | Shares | Defined | 2026-08-13 | |
| 2026-06-30 | $1,310,960 | 7,000 | Call | Defined | 2026-08-13 | |
| 2026-03-31 RVMDW | — | 886 | Shares | Defined | 2026-05-05 | |
| 2026-03-31 | $729,375 | 7,500 | Call | Defined | 2026-05-05 | |
| 2026-03-31 | $426,615,424 | 4,386,791 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $245,954,181 | 3,087,937 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $50,854,664 | 1,088,965 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $18,937,762 | 514,753 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $17,047,302 | 482,107 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 RVMDW | — | 2,692 | Shares | Sole | 2025-02-14 | |
| 2024-12-31 | $13,112,506 | 299,783 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 RVMDW | — | 28 | Shares | Sole | 2024-11-14 | |
| 2024-09-30 | $8,756,131 | 193,079 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 RVMDW | — | 475 | Shares | Sole | 2024-08-14 | |
| 2024-06-30 | $8,451,381 | 217,763 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 RVMDW | — | 91 | Shares | Sole | 2024-05-13 | |
| 2024-03-31 | $9,829,473 | 304,979 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 RVMDW | — | 971 | Shares | Sole | 2024-02-09 | |
| 2023-12-31 | $8,792,083 | 306,558 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $2,689,360 | 97,159 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $3,650,144 | 136,454 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,996,898 | 138,361 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $3,993,255 | 167,643 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $644,902 | 32,703 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $799,712 | 41,032 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $2,299,700 | 90,149 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,879,950 | 114,420 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,228,298 | 117,350 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $34,850 | 1,098 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $65,975 | 1,438 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $47,626 | 1,203 | Shares | Sole | 2021-02-11 | |
| 2020-06-30 | $154,440 | 4,892 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $183,408 | 8,371 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||